These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11641970)

  • 21. A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team.
    Aberg JA; Williams PL; Liu T; Lederman HM; Hafner R; Torriani FJ; Lennox JL; Dube MP; MacGregor RR; Currier JS;
    J Infect Dis; 2003 Apr; 187(7):1046-52. PubMed ID: 12660918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of subclinical Mycobacterium avium intracellulare complex infection in immunodeficient HIV-infected patients treated with zidovudine.
    Mallal SA; James IR; French MA
    AIDS; 1994 Sep; 8(9):1263-9. PubMed ID: 7802978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern of utilization of rifabutin for prophylaxis of Mycobacterium avium complex among patients with advanced human immunodeficiency virus disease in a community setting.
    Mandigo K; Hogg RS; Phillips P; Barber C; Le T; Bessuille E; Black W; O'Shaughnessy MV; Schechter MT; Montaner JS
    Tuber Lung Dis; 1996 Jun; 77(3):233-8. PubMed ID: 8758106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease.
    Dautzenberg B
    Drugs; 1997; 54 Suppl 2():1-7; discussion 28-9. PubMed ID: 9358194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low incidence of colonization and no cases of disseminated Mycobacterium avium complex infection (DMAC) in Brazilian AIDS patients in the HAART era.
    Gadelha A; Accácio N; Grinzstejn B; Veloso V; da Silveira LB; Fandinho F; Saad MH; Lourenço MC; Rolla V
    Braz J Infect Dis; 2002 Oct; 6(5):252-7. PubMed ID: 12495607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mycobacterium avium infection in HIV-infected patients: epidemiology, diagnosis, prevention and treatment].
    Schneider MM; Reiss P; Borleffs JC; Rozenberg-Arska M; Hoepelman IM
    Ned Tijdschr Geneeskd; 1997 Jan; 141(2):80-3. PubMed ID: 9036351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis.
    Bayoumi AM; Redelmeier DA
    AIDS; 1998 Aug; 12(12):1503-12. PubMed ID: 9727572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mastitis due to Mycobacterium avium complex in an HIV-infected woman taking highly active antiretroviral therapy.
    Cunningham CO; Selwyn PA
    AIDS Patient Care STDS; 2003 Nov; 17(11):547-50. PubMed ID: 14746662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
    Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
    MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of highly active antiretroviral therapy on onset of Mycobacterium avium complex infection and cytomegalovirus disease in patients with AIDS.
    Baril L; Jouan M; Agher R; Cambau E; Caumes E; Bricaire F; Katlama C
    AIDS; 2000 Nov; 14(16):2593-6. PubMed ID: 11101072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease.
    Havlir DV; Torriani FJ; Schrier RD; Huang JY; Lederman MM; Chervenak KA; Boom WH
    J Clin Microbiol; 2001 Jan; 39(1):298-303. PubMed ID: 11136787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoproliferative responses to mitogens and prepared antigens of M. avium complex in patients with HIV infection.
    Novak RM; Koirala J; Sirdar ML; D'Alfonso-Laghi N; Moreira L; Pitrak DL; Ghassemi M
    J Clin Immunol; 2000 Jan; 20(1):62-7. PubMed ID: 10798609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
    Moore RD; Chaisson RE
    Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
    Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD;
    N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylaxis against Mycobacterium avium-intracellulare complex infections in human immunodeficiency virus-infected patients.
    Nightingale SD
    Infection; 1997; 25(1):67-70. PubMed ID: 9039547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discontinuation of secondary prophylaxis in AIDS patients with disseminated non-tuberculous mycobacteria infection.
    Liao CH; Chen MY; Hsieh SM; Sheng WH; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2004 Feb; 37(1):50-6. PubMed ID: 15060688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS.
    Craft JC; Notario GF; Grosset JH; Heifets LB
    Clin Infect Dis; 1998 Oct; 27(4):807-12. PubMed ID: 9798037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
    Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
    N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discontinuation of Mycobacterium avium complex prophylaxis in patients with a rise in CD4 cell count following highly active antiretroviral therapy.
    Gill J; Moyle G; Nelson M
    AIDS; 1998 Apr; 12(6):680. PubMed ID: 9583614
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.